Zhao Yuxi Y - OmicsDI

Show results for

Unknown (38)
Proteomics (4)
Metabolomics (1)

Organisms

Homo sapiens (2)
Alphavirus (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Botrytis cinerea (2)
Chlorella vulgaris (2)
Clostridium perfringens (2)
Enterovirus A71 (2)
Eukaryota (2)
Fungi (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Tripsacum dactyloides (2)

Repository

iProX (2)
pride (2)
MetaboLights (1)

Technology Type

Mass Spectrometry (2)
Shotgun proteomics (2)
Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2022 (3)

CHEBI ID

CHEBI:175931 (1)
CHEBI:132820 (1)
CHEBI:181036 (1)
CHEBI:75642 (1)
CHEBI:176884 (1)
CHEBI:49125 (1)
CHEBI:75098 (1)
CHEBI:175611 (1)
CHEBI:32491 (1)
CHEBI:132821 (1)
CHEBI:114954 (1)
CHEBI:66287 (1)
CHEBI:69671 (1)
CHEBI:3461 (1)
CHEBI:167540 (1)
CHEBI:166612 (1)
CHEBI:64907 (1)
CHEBI:167703 (1)
CHEBI:167702 (1)
CHEBI:80897 (1)
CHEBI:17527 (1)
CHEBI:134253 (1)
CHEBI:8185 (1)
CHEBI:6373 (1)
CHEBI:139424 (1)
CHEBI:75644 (1)
CHEBI:9925 (1)
CHEBI:75795 (1)
CHEBI:75627 (1)
CHEBI:75349 (1)

Metabolite Name

3,3',4-O-Trimethylellagic acid (1)
5,4'-Dihydroxy-3,6,7,3'-tetramethoxyflavone (1)
(-)-Epicatechin-3-(3''-O-methyl)gallate (1)
Physcion-8-O-glucoside (1)
Juglone; 5-Hydroxy-1,4-naphthoquinone (1)
LysoPC 18:2 (2n isomer) (1)
Matairesinol-4'-O-glucoside (Matairesinoside) (1)
1,2,3,6-Tetra-O-Galloyl-D-Glucose (1)
Chrysophanol-8-O-glucoside (1)
Cytidine 5'-monophosphate (Cytidylic acid) (1)
Scopoletin (7-Hydroxy-5-methoxycoumarin) (1)
3-Carbamyl-1-methylpyridinium (1-Methylnicotinamide) (1)
LysoPE 16:0 (2n isomer) (1)
LysoPC 18:0 (2n isomer) (1)
LysoPC 16:0 (2n isomer) (1)
Apigenin-7-O-glucoside (Cosmosiin) (1)
LysoPC 18:3 (2n isomer) (1)
LysoPE 18:1 (2n isomer) (1)
Avicularin (Quercetin-3-O-alpha-L-arabinofuranoside) (1)
D-Panose (1)
Kaempferol-3-O-robinoside-7-O-rhamnoside (Robinin) (1)
Sodium Valproate (1)
2,5-Dihydroxybenzoic acid; Gentisic Acid (1)
Naringenin-7-O-Neohesperidoside (Naringin) (1)
Quercetin-3-O-rhamnoside (Quercitrin) (1)
Kaempferol-3-O-glucuronide (1)
Sudachitin (1)
Rhamnocitrin (7-Methylkaempferol) (1)
LysoPC 18:1 (2n isomer) (1)
LysoPC 16:1 (2n isomer) (1)

Release Date

2024 (11)
2023 (6)
2022 (6)
2025 (5)
2021 (5)
2026 (1)
2020 (1)
2017 (1)
2016 (1)
2015 (1)

Lab affiliation

Shenzhen Sixth People's Hospital: Shenzhen, Guangdong, CN (2)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

Quantitative label-free proteomic comparison of the omadacycline-induced E. faecium isolates vs initial separation

Quantitative label-free proteomic comparison of the omadacycline-induced E. faecium isolates vs initial separation type.

ORGANISM(S): Enterococcus faecalis (Streptococcus faecalis)

2022-02-17 | PXD029978 | Pride

Omadacycline E. faecium Label-free proteomic

Antibacterial Activities and Action Mode of Anti-hyperlipidemic Lomitapide Against Staphylococcus aureus_1

Lomitapide has been approved by FDA for years in reducing levels of low-density lipoprotein (LDL) in cases of familial hypercholesterolemia, whereas the antibacterial effect of lomitapide remains elusive. In this study, the inhibitory activities of lomitapide against Staphylococcus aureus, including...

ORGANISM(S): Staphylococcus aureus

2022-03-29 | PXD031706 | Pride

Staphylococcus aureus lomitapide antibiotic resistance drug reposition

Effects of mulch films with different thicknesses on the microbial community of tobacco rhizosphere soil in Yunnan laterite.

Not available

S-EPMC11456438 | biostudies-literature

Combination of susceptibility gene and traditional risk factors might enhance the performance of coronary heart disease screening strategy.

Not available

S-EPMC5620315 | biostudies-literature

Identification of an unrecognized circRNA associated with development of renal fibrosis.

Not available

S-EPMC9845265 | biostudies-literature

Exploring the Anti-Cancer mechanism of Cardiac Glycosides using proteome integral solubility alteration approach

Cancer remains a significant global health challenge, necessitating the development of innovative and cost-effective treatments. Drug repurposing, particularly of cardiac glycosides (CGs), offers a promising strategy to expedite the discovery of anti-tumor drugs. This study employs proteome integral...

ORGANISM(S): Homo Sapiens

PXD052740 |

Effects of cassava pellets and enzymes addition on growth performance, meat quality, serum biochemical indices and cecum microbiota of broilers.

Not available

S-EPMC11635651 | biostudies-literature

P-hydroxybenzoic acid positively affect the Fusarium oxysporum to stimulate root rot in Panax notoginseng.

Not available

S-EPMC10920001 | biostudies-literature

Phytochemicals from Anneslea fragrans Wall. and Their Hepatoprotective and Anti-Inflammatory Activities.

Not available

S-EPMC10384535 | biostudies-literature

Complete cox 1 gene and ITS sequence of Hirudinaria manillensis and molecular evolution analysis.